Results 221 to 230 of about 20,192 (256)
Some of the next articles are maybe not open access.
Acta Ophthalmologica, 1980
Thirty‐eight patients with ocular hypertension or glaucoma were treated with topical timolol for 12–30 months (mean 20). A long lasting hypotensive effect of timolol eyedrops was found. However a need to increase therapy during the follow‐up period was noted especially in the glaucoma group.
N. Marén, Berit Calissendorff
openaire +3 more sources
Thirty‐eight patients with ocular hypertension or glaucoma were treated with topical timolol for 12–30 months (mean 20). A long lasting hypotensive effect of timolol eyedrops was found. However a need to increase therapy during the follow‐up period was noted especially in the glaucoma group.
N. Marén, Berit Calissendorff
openaire +3 more sources
Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma
Pediatric dermatology, 2016The success of oral propranolol for treatment of infantile hemangiomas (IHs) has led practitioners to use topical β‐blockers. In preterm infants, clinicians frequently turn to topical timolol, with the presumption that topical application will result in ...
P. Frommelt +8 more
semanticscholar +1 more source
Treatment of Ocular Pyogenic Granuloma With Topical Timolol
JAMA ophthalmology, 2017Importance Pyogenic granulomas, acquired vascular lesions, form on the ocular or palpebral surface related to inflammation from chalazia, trauma, or surgery. They can be unsightly, spontaneously bleed, and cause irritation to patients.
Isdin Oke +4 more
semanticscholar +1 more source
Archives of Ophthalmology, 1984
To the Editor. —The article comparing efficacy and side effects of betaxolol and timolol in lowering intraocular pressures by Berry et al 1 in the JanuaryArchivesraises several interesting points. The comparison between the two drugs was not conducted on a random sample of eyes with elevated IOP.
openaire +2 more sources
To the Editor. —The article comparing efficacy and side effects of betaxolol and timolol in lowering intraocular pressures by Berry et al 1 in the JanuaryArchivesraises several interesting points. The comparison between the two drugs was not conducted on a random sample of eyes with elevated IOP.
openaire +2 more sources
Timolol-Pilocarpine Combined vs Timolol and Pilocarpine Given Separately
American Journal of Ophthalmology, 1989In a controlled, double-observer, multicenter study, we compared the effect of a fixed combination of timolol 0.5%-pilocarpine 4% twice a day with that of timolol 0.5% twice a day plus pilocarpine 4% three times a day in 80 patients with open-angle glaucoma whose intraocular pressure was greater than 21 mm Hg on timolol 0.5% twice a day alone ...
örjan Wallin +3 more
openaire +3 more sources
Ophthalmic Pyogenic Granulomas Treated With Topical Timolol-Clinical Features of 17 Cases.
Ophthalmic Plastic and Reconstructive Surgery, 2018PURPOSE Topical timolol has been increasingly demonstrated to be an effective treatment for pyogenic granulomas (PG). The authors review the treatment outcomes of 17 patients with ocular PG treated with topical timolol.
Lauren N DeMaria +2 more
semanticscholar +1 more source
Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption
Pediatric dermatology, 2016Topical use of timolol for infantile hemangiomas has recently emerged with promising results. It is unknown whether topical β‐blockers act locally or if their effect is partly due to systemic absorption.
L. Weibel +8 more
semanticscholar +1 more source
2007
Timolol is a non-selective, beta adrenoceptor antagonist at beta-1 and beta-2 adrenoceptors. It lacks the partial agonist and local anesthetic properties that some drugs in this class have. It is most commonly used to treat glaucoma and cardiovascular diseases. Timolol is moderately lipophilic. Absorption of timolol after topical application to the eye
openaire +2 more sources
Timolol is a non-selective, beta adrenoceptor antagonist at beta-1 and beta-2 adrenoceptors. It lacks the partial agonist and local anesthetic properties that some drugs in this class have. It is most commonly used to treat glaucoma and cardiovascular diseases. Timolol is moderately lipophilic. Absorption of timolol after topical application to the eye
openaire +2 more sources
Ocular and cardiac β-antagonism by timolol prodrugs, timolol and levobunolol
Current Eye Research, 1988Topically applied O-butyryl timolol, O-pivaloyl timolol and levobunolol (0.25 micrograms) antagonized isoproterenol-induced ocular hypotension for 8 hrs whereas timolol (0.25 micrograms) was shorter acting (4 hrs). Timolol (25 micrograms) produced greater antagonism of isoproterenol-induced tachycardia than did O-butyryl and O-pivaloyl timolol (25 ...
Vincent H.L. Lee +3 more
openaire +2 more sources
Travoprost/timolol fixed combination
Expert Opinion on Pharmacotherapy, 2008Travoprost and timolol are topical ocular hypotensive medications that have been used in the treatment of glaucoma. The fixed combination eye drop, Duotrav (travoprost 0.004% and timolol maleate 0.5%), has recently been introduced into the market.In this paper, the results of clinical trials and existing data on the performance of travoprost/timolol ...
Michael Herceg, Robert J. Noecker
openaire +2 more sources